Strategic Marketing Consultant
Expert marketing, strategy & business development consulting to medical device, pharmaceutical & healthcare clients.

NOTEWORTHY PROJECT CONTRACTS
• Abbott Molecular・Global Marketing, Oncology (Multiple Myeloma, Acute Myeloid Leukemia, Non-Small Cell Lung Cancer)
• AstraZeneca ・Global Marketing Oncology (ENHERTU, Metastatic Breast Cancer, Targeted Immunotherapy)
• Abbott Molecular ・Competitive Intelligence, Infectious Disease.
• BAXTER International・Portfolio Optimization for three therapies, globally.

ABBOTT MOLECULAR (ONCOLOGY)
Revitalized global oncology portfolio ($70M) by launching new products, illuminating growth paths and strategic partnerships for Companion Diagnostics (CDx). Orchestrated launch planning, positioning, and tactical execution through cross-functional collaboration with Medical Affairs, R&D, Regulatory, Sales Training and global affiliates. Developed MLR compliant global marketing toolkit and content, managed communications across customers, distributors and affiliates.
• Led global CDx launch for Multiple Myeloma targeted therapy, negotiated & executed commercialization plan with biopharma partner.
• Accelerated North America CDx launch for Acute Myeloid Leukemia, reducing time-to-market by three (3) months following early FDA targeted therapy approval. Additionally, launched globally three (3) related oncology auxiliary products.
• Advanced product development for two long-term CDx assets for Breast and Non-Small Cell Lung Cancer targeted therapies.

Led launch readiness (LRR) and alliance co-promotion effort of a $2.5B+ metastatic breast & gastric cancer immunotherapy (ENHERTU). Coordinated internal and agency teams for promotional tactics and campaign concept development aligned with global brand strategy imperatives, positioning and messaging. Added optimizations to the annual brand planning process.
• Engaged HCPs and patients through multiple channels including therapy guide, patient brochure, promotional speaker deck, congress planning, Advisory Boards & White Paper while ensuring MLR compliance.
• Partnered with R&D, Market Access, Business Insights to develop KPIs for brand strategy measurement and the target product profile.

Reimagined the strategic planning framework and growth strategy to enable a $400M organization improve health outcomes for patients at reduced medical cost by identifying, evaluating, and prioritizing targeted Digital Health & Direct-to-Patient opportunities. Presented executive-level recommendations aligned with financial plans and supported by business cases, financial models, trend and market analysis on competition and patient preferences. Cultivated strong relationships with external and internal stakeholders.
• Partnered with Novo Nordisk Market Access to launch personalized obesity support for Type II diabetes patients on anti-obesity medication (WEGOVY). Refined patient experience, positioning, pricing and business case, resulting in a ~$1M deal.
• Generated $24M in revenue (per 1M kits sold) and increased retail traffic by partnering with Abbott to launch the BinaxNOW COVID-19 home test kit in HealthHubs. Revitalized marketing strategy to drive consumer engagement & growth.

ABBOTT MOLECULAR (ONCOLOGY & INFECTIOUS DISEASE)
Delivered actionable business insights to guide marketing tactics and executive decision making. Monitored market competition, industry trends, financial performance, market size and market share impact through market research, news feeds, earnings calls and data analytics.

PRODUCT PORTFOLIO OPTIMIZATION/SIMPLIFICATION
Expanded gross profit margin by ~$50MM through strategic SKU pruning and robust business cases. Partnered with Medical Affairs, Commercial, Supply Chain and Manufacturing to optimize portfolios across Renal, Medication Delivery and Clinical Nutrition. Evaluated global supplier partnerships to ensure contract profitability and value alignment.

Reported directly to the President of a $300M+ business, overseeing department operations and talent development. Led strategy sessions to define growth strategy, address strategic questions, identify portfolio gaps and winning product profiles for business development initiatives aligned with business plans. Influenced top leadership on partnerships (M&A, licensing, joint ventures, equity investments). Built opportunity pipeline using frameworks and tools to assess inorganic opportunities valued $50M to $1B+ for blood, cell therapy and operating room business units. Prevented suboptimal acquisitions, resulting in ~$500M investment savings. Primary contact person engaging with outside company leaders, Private Equity and Investment Banks for due diligence, site visits, product demonstrations, data rooms and business development related documentation (mNDA, CIM, IOI, LOI, term sheets, contracts). Guided the strategic planning process across business units for annual LRP & business plans.

DIGITAL MARKETING · PATIENT LOYALTY (IMMUNOLOGY, RENAL)
Handpicked to lead cross-functional teams implementing strategic marketing initiatives and customer experience enhancements across sixteen (16) brands. Added memorable touchpoints & content on digital ecosystem (patient/HCP websites, social, video, digital apps), achieved 15% operational savings. Managed SOWs, budget, timeline, and agency/vendor partnerships. Resolved conflicts “win-win”.
• Increased physician (HCP) prescriptions for ZEMPLAR ($230M sales, Renal Care) by spearheading the development and launch of a digital titration dosing calculator app. Resolved dosing confusion and empowered HCPs to optimize patient treatment outcomes.
• Differentiated personalized care for Crohn’s disease patients (HUMIRA, $20B+ sales) via virtual access to Pharmacy Solutions. Enabled connectivity w/ Patient Relations and on-site care providers for treatment administration, education, insurance claims.

PHARMACEUTICAL PRODUCTS DIVISION (ONCOLOGY, VIROLOGY, CARDIOVASCULAR)
Product marketing and project management rotations across a broad pharma portfolio.

PRODUCT MARKETING · VIROLOGY (HIV Kaletra)
PRODUCT LAUNCHES · ONCOLOGY (LUPRON, Prostate Cancer)
PRODUCT LAUNCHES · CARDIOVASCULAR (CERTRIAD/CRESTOR, Mixed Dyslipidemia)
COMMERCIAL PROGRAM MANAGEMENT OFFICE · MARKETING OPERATIONS, CAMPAIGNS, CRM, MARKETING ANALYTICS

Supported strategy via analysis & execution of business transformations turning inefficiencies into EBITDA gain drivers (12%). Analyzed efficiency of client operating models via proprietary methodology and industry benchmarks, identified gaps relative to competitors, recommended improvements & financial justification for process transformation.